With regards to their safety profile CTx-induced grade ≥3 toxicities including rash, anemia, diarrhea, and anorexia were found to be increased in combined CTx-targeted therapy compared to CTx [14, 55, 56] or compared to targeted monotherapy [14]. The gene discussed is CYP27A1; the disease is anemia.